Compounds > diphenhydramine

diphenhydramine and piroxicam

diphenhydramine has been researched along with piroxicam in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (33.33)	18.2507
2000's	3 (20.00)	29.6817
2010's	7 (46.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrupt, PA; Jolliet, P; Morin, C; Morin, D; Pagliara, A; Rihoux, JP; Testa, B; Tillement, JP; Urien, S	1
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Ahman, M; Holmén, AG; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Gozalbes, R; Pineda-Lucena, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Balciunas, BA; Siegel, MA	1
Galli, SJ; Masson, S; Perdue, MH; Wershil, BK	1
Crowe, SE; Perdue, MH; Sestini, P	1
Benjamin, M; Perdue, MH; Savedia, S; Wang, L	1
Hale, LP; Hampton, DD	1

Reviews

1 review(s) available for diphenhydramine and piroxicam

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

14 other study(ies) available for diphenhydramine and piroxicam

Article	Year
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist. Journal of medicinal chemistry, 1998, Mar-12, Volume: 41, Issue:6 Topics: Alkanes; Animals; Biological Transport; Blood Proteins; Brain; Cetirizine; Histamine H1 Antagonists; Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydroxyzine; Isomerism; Models, Molecular; Molecular Conformation; Octanols; Rats; Water	1998
Predicting blood-brain barrier permeation from three-dimensional molecular structure. Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11 Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
QSAR-based solubility model for drug-like compounds. Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19 Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013
Medication can induce severe ulcerations. Journal of the American Dental Association (1939), 1991, Volume: 122, Issue:9 Topics: Adult; Aluminum Hydroxide; Diagnosis, Differential; Diphenhydramine; Drug Combinations; Humans; Magnesium Hydroxide; Male; Piroxicam; Stomatitis, Aphthous; Tetracycline	1991
Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/Wv mice by bone marrow transplantation. The Journal of clinical investigation, 1991, Volume: 87, Issue:2 Topics: Anaphylaxis; Animals; Biological Transport; Bone Marrow Transplantation; Diphenhydramine; In Vitro Techniques; Intestinal Diseases; Intestinal Mucosa; Mast Cells; Mice; Mutation; Piroxicam; Serotonin; Tetrodotoxin	1991
Allergic reactions of rat jejunal mucosa. Ion transport responses to luminal antigen and inflammatory mediators. Gastroenterology, 1990, Volume: 99, Issue:1 Topics: Animals; Antigens; Biological Transport; Capsaicin; Diphenhydramine; Electrolytes; Hypersensitivity; Intestinal Mucosa; Ions; Jejunum; Ketanserin; Ovalbumin; Piroxicam; Rats; Rats, Inbred Strains	1990
The role of mast cells in intestinal immunophysiology. Advances in experimental medicine and biology, 1995, Volume: 371A Topics: Animals; Cholera Toxin; Cyclooxygenase Inhibitors; Diphenhydramine; Histamine H1 Antagonists; Immunoglobulin E; Immunologic Deficiency Syndromes; Intestinal Mucosa; Intestines; Ketanserin; Mast Cells; Mice; Mice, Mutant Strains; Myenteric Plexus; Ovalbumin; Piroxicam; Serotonin Antagonists; Stem Cell Factor; Submucous Plexus; Substance P; Tetrodotoxin	1995
Mast cells are critical for protection against peptic ulcers induced by the NSAID piroxicam. PloS one, 2011, Volume: 6, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diphenhydramine; Dose-Response Relationship, Drug; Drug Synergism; Gastric Mucosa; Histamine; Humans; Mast Cells; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Peptic Ulcer; Piroxicam; Tumor Necrosis Factor-alpha	2011